![](https://scandasia.com/wp-content/uploads/2021/07/isr-opxiupfba3lzl501k1p0uld3lsn5cyh30tb9l7b8oc-348x215.png)
ISR signs investment agreement with Singaporean company for development of inhaled covid-19 vaccine
Sweden-based ISR Immune System Regulation Holding AB (publ), which develops inhalation vaccines against Covid-19 has signed an investment agreement with Singapore Resources Development PTE. Ltd, the company announced in this press …
ISR signs investment agreement with Singaporean company for development of inhaled covid-19 vaccine Read More